Safety of dietary supplementation with arginine in adult humans 4
Semaglutide mimics the action of GLP-1 (glucagon-like peptide 1)
Similar lean-mass proportion is not the same as builds muscle or preserves all muscle automatically. Across obesity treatment generally, lean body mass loss still occurs with weight reduction, including with GLP-1based therapies, and newer expert commentary continues to emphasize muscle preservation as a major clinical priority
Clinical research has shown that after discontinuing tirzepatide, people often experience increased hunger and may gradually return to previous eating patterns, which can lead to weight regain
46 In stroke, after ischemia and then reperfusion, mitochondria do not work as well, which means less energy and a flood of harmful reactive oxygen species, and that leads to cell damage and death
In summary, in adults dealing with overweight or obesity (with at least one weight-related comorbidity), semaglutide treatment resulted in significant and sustained weight loss over the 104-week period compared to placebo